Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?
- 1 February 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (3), 461-462
- https://doi.org/10.1016/s0002-9149(98)00889-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Angiotensin-Converting Enzyme in the Human HeartCirculation, 1995
- Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1995
- Identification of functional angiotensin II receptors on rat cardiac fibroblasts.Circulation, 1993
- Mistyping ACE heterozygotes.Genome Research, 1993
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)Nucleic Acids Research, 1992
- Regulatory Mechanisms of Myocardial Hypertrophy and Fibrosis: Results of in vivo StudiesCardiology, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990